ÂÜÀòÂÒÂ×

Celeste Scotti MD, PhD, currently serves as a Member of the Board of Directors at Fondazione AriSLA and as Head of Research and Development at Fondazione Telethon. Prior experience includes serving as Executive Director and Global Program Clinical Head at Novartis, where responsibilities encompassed clinical leadership for programs related to Osteoarthritis and NASH, as well as managing the fast-tracked LNA043 program. Additionally, Celeste has held positions at Libera Università Vita-Salute San Raffaele as a Contract Professor and was a PhD Candidate in Bioengineering at Universitätsspital Basel. Celeste's clinical background includes roles as an Orthopaedic Surgeon and Principal Investigator at ISTITUTO ORTOPEDICO GALEAZZI SPA, and a Resident in Orthopaedic Surgery at the University of Milan. Educational qualifications include an M.D. from Libera Università Vita-Salute San Raffaele, Board Certification in Orthopaedic Surgery, and a Ph.D. from the University of Basel, focusing on Bioengineering and Biomedical Engineering.